Last Updated on October 11, 2024 by The Health Master
USFDA approval
In a major stride forward, Lupin, the renowned pharmaceutical company, has secured USFDA approval from the United States Food and Drug Administration (USFDA).
This USFDA approval is for its abbreviated new drug application concerning Pirfenidone Tablets.
These tablets, available in strengths of 267 mg and 801 mg, are slated to be introduced as a generic alternative to Esbriet Tablets, also available in the same strengths and manufactured by Hoffmann La Roche Inc.
Stamp of USFDA Approval:
Lupin’s announcement of receiving approval from the USFDA marks a significant milestone for both the company and patients seeking accessible treatment options.
The regulatory nod serves as a testament to the quality and safety of Lupin’s generic Pirfenidone Tablets.
Cost-Effective Solution for Patients:
This regulatory breakthrough is poised to introduce a more cost-effective avenue for patients in need of Pirfenidone, a medication primarily prescribed for the treatment of idiopathic pulmonary fibrosis.
With Lupin’s generic version hitting the market, patients can expect a more affordable alternative without compromising on the efficacy and therapeutic benefits of the drug.
Manufacturing Hub in Pithampur:
Lupin’s commitment to quality extends beyond the approval itself.
The company has earmarked its state-of-the-art manufacturing facility in Pithampur, India, for producing the newly approved Pirfenidone Tablets.
This strategic choice aligns with Lupin’s renowned dedication to adhering to stringent manufacturing standards while ensuring a steady supply of high-quality medications.
Market Potential and Growth Prospects:
The approval of Lupin’s Pirfenidone Tablets holds substantial promise in terms of market share and growth opportunities.
With the Reference Listed Drug (RLD) Esbriet holding an estimated annual sales figure of USD 218 million in the U.S. (according to IQVIA MAT data from June 2023), Lupin’s generic version stands to capture a significant portion of this lucrative market.
The introduction of an affordable yet equally effective option is likely to reshape the competitive landscape and enhance accessibility for patients.
Conclusion:
Lupin’s achievement in gaining USFDA approval for its generic Pirfenidone Tablets stands as a transformative event in the pharmaceutical realm.
With a commitment to quality, affordability, and accessibility, Lupin is primed to make a substantial impact on the market while offering patients a more budget-friendly alternative for their medical needs.
As the company initiates production in its Pithampur facility, the medical community and patients alike await the positive outcomes this approval is bound to bring.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
USFDA approval granted for Generic Doxepin Hydrochloride Capsules
USFDA gives approval for Guaifenesin ER Tablets
USFDA gives ANDA approval for Tacrolimus Ointment 0.03%
USFDA gives nod for this cancer treatment generic injection
USFDA gives approval for Icatibant injection
USFDA gives approval for this drug to treat Rare Blood Disease
Huge quantities of drugs seized from Nigerian: UP
NMC Puts New Medical Practitioner Conduct Rules on Hold
Drug alert: 51 out of 1306 samples declared as NSQ in July 2023
USFDA approval granted for Generic Doxepin Hydrochloride Capsules
USFDA issued EIR to Torrent Pharma: Gujarat
Pharmacy Practice Regulations 2015 implemented: Mizoram
Recommendations for expediting TMR for Medical Devices
USFDA gives approval for Guaifenesin ER Tablets
Key Requirements for RTI Orders: High Court’s Directives
Gujarat FDCA: M-Governance soon for Drug Manufacturers and Medical Stores
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
